Kamada (KMDA) Long-Term Investments (2012 - 2022)
Kamada (KMDA) posted quarterly Long-Term Investments of $102.0 million for Q4 2022, down 1.88% year-on-year from $103.9 million in Q4 2021, and down 1.88% on a QoQ basis from $103.9 million in Q4 2021.
Kamada (KMDA) Long-Term Investments (2012 - 2022) Analysis & Trends
Kamada (KMDA) has reported Long-Term Investments for 10 consecutive years, with $102.0 million the latest figure, recorded in Q4 2022.
- Quarterly Long-Term Investments fell 1.88% year-over-year to $102.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $102.0 million (down 1.88% YoY) and the FY2022 annual result came in at $102.0 million, down 1.88% from the prior year.
- Long-Term Investments declined to $102.0 million in Q4 2022 per KMDA's latest filing, from $103.9 million in the prior quarter.
- Over the last five years, Long-Term Investments for KMDA reached as high as $156.5 million in Q2 2019 and fell as low as $8.6 million in Q4 2019.
- A 4-year average of $98.2 million and a median of $115.1 million in 2018 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2018 — Long-Term Investments rose 29.43% — and 2019, when it fell 2.04%.
- Year by year, Long-Term Investments stood at $8.7 million in 2018, then declined by 2.04% to $8.6 million in 2019, then soared by 1114.19% to $103.9 million in 2021, then decreased by 1.88% to $102.0 million in 2022.
- According to Business Quant data, Long-Term Investments over the past three periods registered $102.0 million, $103.9 million, and $8.6 million for Q4 2022, Q4 2021, and Q4 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 101.96 Mn |
| Dec 31, 2021 | 103.91 Mn |
| Dec 31, 2019 | 8.56 Mn |
| Jun 30, 2019 | 156.49 Mn |
| Mar 31, 2019 | 145.10 Mn |
| Dec 31, 2018 | 8.74 Mn |
| Sep 30, 2018 | 115.12 Mn |
| Jun 30, 2018 | 123.69 Mn |
| Mar 31, 2018 | 120.53 Mn |
| Dec 31, 2017 | 8.60 Mn |
| Sep 30, 2017 | 111.99 Mn |
| Jun 30, 2017 | 100.20 Mn |
| Mar 31, 2017 | 93.13 Mn |
| Dec 31, 2016 | 9.16 Mn |
| Sep 30, 2016 | 94.60 Mn |
| Jun 30, 2016 | 98.57 Mn |
| Mar 31, 2016 | 106.64 Mn |
| Dec 31, 2015 | 101.99 Mn |
| Sep 30, 2015 | 108.43 Mn |
| Jun 30, 2015 | 1.46 Mn |